Physician profile
Harvey A Oliver
NPI 1669735676
$11,783.02
in general payments reported to CMS, 2019-2025
11 companies · $2,828 in 2025
The $2,828 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $1,965 · 2021: $3,641 · 2022: $749 · 2023: $1,871 · 2024: $385 · 2025: $2,828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,639 · Food and Beverage: $2,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,639.45 |
| Food and Beverage | $2,444.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conetic Solutions, INC. | $6,387.34 | 2020-2025 | |
| Arthrex, INC. | $3,048.39 | 2022-2025 | |
| Arcuro Medical INC | $1,207.09 | 2025 | Superball |
| Medinc of Texas | $681.50 | 2020 | |
| Smith+Nephew, INC. | $243.15 | 2019 | |
| Zimmer Biomet Holdings, INC. | $79.64 | 2019 | |
| Catalyst Orthoscience | $50.65 | 2025 | |
| Stryker Corporation | $26.42 | 2022 | |
| Bioventus LLC | $21.92 | 2019 | |
| Vericel Corporation | $20.02 | 2025 | Maci |
| Kinex Medical Company LLC | $16.90 | 2024 | Kinex Kck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harvey Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.